Edwards Lifesciences Corporation Share Price
Equities
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 68.04 USD | -0.30% |
|
+3.21% | -10.64% |
| 11/09 | QuidelOrtho Corporation Appoints Lee Bowman as Chief Human Resources Officer | CI |
| 10/09 | UBS Cuts Edwards Lifesciences Price Target to $75 From $90, Maintains Neutral Rating | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Enjoy this offer
* See conditions on site
| Capitalization | 4.11TCr 3,45100Cr | P/E ratio 2024 * |
29.8x | P/E ratio 2025 * | 25.9x |
|---|---|---|---|---|---|
| Enterprise value | 4.52TCr 3,79400Cr | EV / Sales 2024 * |
6.55x | EV / Sales 2025 * | 6.24x |
| Free-Float |
91.34% | Yield 2024 * |
-
| Yield 2025 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Edwards Lifesciences Corporation
More recommendations
More press releases
More news
| 1 day | +1.65% | ||
| 1 week | -0.99% | ||
| Current month | -2.44% | ||
| 1 month | +5.58% | ||
| 3 months | -21.55% | ||
| 6 months | -24.86% | ||
| Current year | -10.49% |
1 week
65.47
68.40
1 month
64.7071.80
Current year
58.9396.12
1 year
58.9396.12
3 years
58.93131.73
5 years
51.51131.73
10 years
16.18131.73
| Director | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/15/01 | |
Scott Ullem
DFI | Director of Finance/CFO | 57 | 01/14/01 |
Todd Brinton
CTO | Chief Tech/Sci/R&D Officer | - | 01/19/01 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chairman | 67 | 13/14/13 | |
Kieran Gallahue
BRD | Director/Board Member | 60 | 10/15/10 |
| Chief Executive Officer | 56 | 01/15/01 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.46% | 41 M€ | +0.06% | - | |
| 2.34% | 18 M€ | +9.16% | - | |
| 1.17% | 23 M€ | +1.53% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| +1.65% | -0.99% | -8.84% | -43.54% | 4.11TCr | ||
| -0.92% | +1.07% | +20.10% | +8.13% | 24TCr | ||
| -1.00% | +2.83% | +8.72% | -17.58% | 20TCr | ||
| +1.38% | +1.91% | +62.37% | +43.90% | 17TCr | ||
| -0.14% | +1.20% | +52.02% | +86.55% | 12TCr | ||
| +0.98% | -0.51% | +11.21% | -9.14% | 6.13TCr | ||
| -0.40% | -3.14% | -11.07% | -27.64% | 4.08TCr | ||
| +0.49% | +0.39% | +22.63% | -21.74% | 3.99TCr | ||
| +1.92% | -0.41% | +30.88% | - | 3.98TCr | ||
| +0.02% | +3.34% | +66.93% | -14.44% | 3.72TCr | ||
| Average | +0.40% | +0.28% | +25.49% | +0.50% | 9.89TCr | |
| Weighted average by Cap. | +0.02% | +1.06% | +28.49% | +12.45% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 580.17Cr 49TCr | 599.46Cr 50TCr |
| Net income | 137.58Cr 12TCr | 156.73Cr 13TCr |
| Net Debt | -313.51Cr -26TCr | -372.25Cr -31TCr |
More financial data
* Estimated data
Employees
19,800
Calendar
23/10/2024
- Q3 2024 Earnings Release (Projected)
Related indices
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/24/13 | 68.15 $ | -0.15% | 3,281,307 |
| 11/24/11 | 68.25 $ | +1.65% | 4,314,396 |
| 10/24/10 | 67.14 $ | +2.18% | 5,696,723 |
| 09/24/09 | 65.71 $ | -1.65% | 6,409,500 |
| 06/24/06 | 66.81 $ | +1.20% | 8,174,841 |
Delayed Quote Nyse, September 12, 2024 at 01:30 am IST
More quotes
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
68.25USD
Average target price
79.82USD
Spread / Average Target
+16.96%
- Stock Market
- Equities
- EW Stock
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition